Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Investors need to be careful while selecting stocks in midcap space as any unfavourable result in state elections would result in a drastic fall in midcaps and smallcaps
 
                                                                                            The escalating load of NPAs, bond yields and decline in credit growth rate are major issues faced by state run banks.
 
                                                                                            Now all eyes are on corporate earnings and Karnataka elections along with crude oil movement, experts suggest.
 
                                                                                            Ashwani Gujral of ashwanigujral.com is of the view that one can sell REC, Bank of India, Asian Paints and HDFC Bank and can buy Tech Mahindra and Natco Pharma.
 
                                                                                            Ashwani Gujral of ashwanigujral.com is of the view that one can buy Ashok Leyland, NMDC and JSW Steel.
 
                                                                                            Gaurang Shah of Geojit Financial Services is of the view that one may prefer Natco Pharma.
 
                                                                                            Ruchit Jain of Angel Broking recommends buying Natco Pharma with a stoploss at Rs 995 and target of Rs 1080 and a buy on GHCL with a stoploss at Rs 286 and target of Rs 327.
 
                                                                                            Ashwani Gujral of ashwanigujral.com is of the view that one can buy HDFC Bank, Natco Pharma, Hindalco Industries and Axis Bank and can sell TCS.
 
                                                                                            Ruchit Jain of Angel Broking is of the view that one may buy NIIT Technologies with a target of Rs 681.
 
                                                                                            Ashwani Gujral of ashwanigujral.com is of the view that one can buy Natco Pharma and Jubilant Life Sciences and sell IRB Infrastructure, Tata Steel and Voltas.
 
                                                                                            According to Ashwani Gujral of ashwanigujral.com, one may stay invested in Natco Pharma.
 
                                                                                            Ashwani Gujral of ashwanigujral.com recommends buying Natco Pharma, Aurobindo Pharma and Ajanta Pharma.
 
                                                                                            Gaurang Shah of Geojit Financial Services feels that Lupin may test Rs 1600.
 
                                                                                            Ashwani Gujral of ashwanigujral.com feels that Jaiprakash Associates may test Rs 24-25.
 
                                                                                            Natco Pharma rallies in trade as Mylan gets US Food and Drug Administration (US FDA) nod for Copaxone. In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities spoke about the impact and his strategy on the stock.
 
                                                                                            Mylan, distribution partner for Natco Pharma in the US market, gets US Food and Drug Administration (US FDA) nod for generic version of Copaxone 20 mg tablet and 40 mg tablet.
 
                                                                                            In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his readings and outlook on specific stocks and sectors.
 
                                                                                            Ashwani Gujral of ashwanigujral.com recommends buying Avanti Feeds, TV Today, GAIL India, KRBL and Hindustan Zinc.
 
                                                                                            ICICI Pru, Natco and OMCs, among others, are on the radar of analysts on Wednesday.
 
                                                                                            Sandeep Wagle of powermywealth.com recommends buying Repco Home Finance and Arvind.
 
                                                                                            Sudip Bandopadhyay, Market Expert recommends buuying Aurobindo Pharma, Natco Pharma and Glenmark Pharma and expects more than 20 percent upside in one year.
 
                                                                                            Sudip Bandhopadhyay, Market Expert is of the view that one can buy Aurobindo Pharma and likes Glenmark Pharma as well as Natco Pharma..
 
                                                                                            Ashwani Gujral of ashwanigujral.com recommends buying Natco Pharma, Canara Bank and Indiabulls Housing Finance.
 
                                                                                            Formulations plant of Dr Reddy's Laboratories at Srikakulam gets inspected and gets 1 observation from United States Foods and Drug Authority (US-FDA). The plant was inspected with zero observations last time.
 
                                                                                            Ashwani Gujral of ashwanigujral.com suggests buying Mahanagar Gas, Natco Pharma and Raymond and prefers Escorts over M&M.